JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Severe hypophosphatemia in hospitalized patients.

Although severe hypophosphatemia has been associated with significant morbidity, little quantitative information is available on the magnitude of the risk. The objective of this study was to determine the frequency and timing of severe hypophosphatemia, the relative risk associated with various medical diagnoses, and the choice of therapy. Among 10,197 patients hospitalized over a 1-year period, the incidence of severe hypophosphatemia (serum phosphate less than or equal to 0.33 mmol/l) was 0.43%. The incidence was 0.91% in alcoholics, 2.42% in septic patients, 10.4% in patients with malnutrition, and 14.6% in patients with diabetic ketoacidosis. The odds ratio for developing the metabolic abnormality was 4.2 (95% confidence interval 2.2-8.1) in alcoholics, 6.4 (1.9-18.9) in septic patients, 46.9 (16.6-125.6) in patients with diabetic ketoacidosis, and 60.7 (31.4-117.5) in malnourished patients. There was a 4-fold increase in mortality in patients with severe hypophosphatemia (18.2 vs. 4.6%; p less than 0.001). The metabolic abnormality was not recognized or was inappropriately treated in 42% of patients. Severe hypophosphatemia is a relatively common finding in hospitalized patients, especially in those with certain well-defined medical conditions. It is associated with significant excess mortality. Its recognition and treatment remain suboptimal.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app